Tweets
If you are not at the table, you are on the menu
https://t.co/c4anIn3aue
@cdowneymd @ACRheumDC
Join a committee
RheumPAC
Write a letter
Write a post card at ACR Hub at #ACR24
Advocacy office hours with ACR staff
#Act4Arthritis & Advocacy 101 on Cap Hill
@RheumNow https://t.co/bpilydxEpB
Links:
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarthritis patients treated with IL-17A (secukinumab) or TNF inhibitors over 2 years.
Key findings:
- New syndesmophytes: 18.2% (SEC 150 mg), 15.8% (SEC 300 mg),… https://t.co/jke6OHdPjZ
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
The future use of a panel of immunological urinary biomarkers as a liquid biopsy for the management of lupus nephritis. Plenary Abstr#1642 @RheumNow #ACR24 https://t.co/waSRVd7FV7
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
@LennMcD @ACRheumDC
Current congress (118th) - very tight margins, paralyzed by the ‘24 elections. Now in lame duck
Many ACR policies made into bills - PA, step rx, copay accumulator, workforce, loan repayment, incr Rx transparency
Needs to be passed into law
@RheumNow #ACR24 https://t.co/1elEUiUAmh
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
@DrLauraCoates presented Sex differences in clinical presentations of PsA:
-Women present >polyarthritis, enthesitis and worse PROs which translates to ⬆️ DAPSAs in spite of less Rx progression.
-Men more oligoarthritis, axial involvement, higher skin disease.
#ACR24… https://t.co/iapZF0nZWX https://t.co/jZ79WfxZwh
Links:
Adela Castro @AdelaCastro222 ( View Tweet )
1 year 2 months ago
🔥Sex matters in PsA
🔑Differences in :
➡️clinical phenotypes
➡️radiographic progression
➡️disease impact
➡️pt perception of disease
➡️response to Rx
#ACR24 @RheumNow https://t.co/iOXQmoxgp0
Caoilfhionn Connolly @CaoilfhionnMD ( View Tweet )
1 year 2 months ago
Dr @andreafava presents their noninvasive biomarker panel that predicted the probability of histologically active LN.
Panel outperformed UPCR, C3, C4 & antidsDNA.
Aid in clinical-decision making? Lots of potential for monitoring tx response.
@Rheumnow #ACR24 abs1642
#ACRbest https://t.co/C7ZNdvbIQ7
Links:
sheila @RHEUMarampa ( View Tweet )
1 year 2 months ago
@LennMcD
@ACRheumDC
Many ACR priorities in bills, needs to be passed in law
Victories:
Incr NIH biomedical research funding, added to DoD funds
Medicare reimbursem and telehealth needs addressed by lame duck congress
Get involved, reach out, write letters
@RheumNow #ACR24 https://t.co/7oCvUFWpx4
Links:
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
Impressive Plenary @andreafava just finished Novel urine protein panel id 12 proteins that predict NIH activity on renal bx better than existing options Improving at 3 mos predicts response at 1 year Could reduce biopsies / modulate tx! #ACR24 @RheumNow Abstr#1642 #ACRbest https://t.co/Gi6u6hAGzj
Links:
Mike Putman @EBRheum ( View Tweet )
1 year 2 months ago
"We look forward to Carol Langfords upcoming leadership at ACR and its newfound focus on ANCA vasculitis as the most important disease" 😆😂
-Phil Seo
#ACR24 @RheumNow
Mike Putman @EBRheum ( View Tweet )
1 year 2 months ago
A study presents a novel urinary biomarker panel that predicts histologically active lupus nephritis (LN) with high accuracy.
Key findings:
- AUC of 90% for predicting NIH Activity Index > 2, outperforming traditional biomarkers.
- Identified 12 critical proteins linked to… https://t.co/6ZhqNaxpQM
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
The 3-4-5 rule for positive MRI in axSpA remains.
The MRI lesion cut-offs demonstrated high performance across different features of axSpA (PsO, AAU,IBD).
Deep fat and deep sclerosis high specificity for axSpA.
#Abst0821 #ACR24 @RheumNow https://t.co/4JM5MHrB8z
Links:
Adela Castro @AdelaCastro222 ( View Tweet )
1 year 2 months ago
